1. Market Research
  2. > Healthcare
  3. > Diagnostics
  4. > In Vitro Diagnostics Market Trends
Europe Immunochemistry Market to 2027 - Regional Analysis and Forecasts by Application ; Product ; End User, and Country

Europe Immunochemistry Market to 2027 - Regional Analysis and Forecasts by Application ; Product ; End User, and Country

  • January 2020
  • 180 pages
  • ID: 5862119
  • Format: PDF
  • By The Insight Partners

Summary

Table of Contents

Search Inside

The Europe immunochemistry market is expected to reach US$ 775.97 Mn in 2027 from US$ 430.82 Mn in 2018. The market is estimated to grow with a CAGR of 6.9% from 2019-2027.
The growth of the immunochemistry market is primarily attributed to the significantly increasing prevalence of cardiovascular diseases and rising incidence of diabetes in the region.However, shortage of skilled professionals is likely to have a negative impact on market growth.

On the other hand, rising healthcare expenditure in Europe is likely to have a positive impact on the growth of the Europe immunochemistry market in the coming years.
The growth of the immunochemistry market is primarily attributed to the significantly increased prevalence of cardiovascular diseases and the rising incidence of diabetes in the region.However, a shortage of skilled professionals is likely to have a negative impact on market growth.

On the other hand, rising healthcare expenditure in Europe is expected to have a positive impact on the growth of the European immunochemistry market in the coming years.
Cardiovascular diseases (CVDs) are likely to endure the most significant cause of mortality and morbidity worldwide.The CVDs include the heart and blood vessels and include cerebrovascular disease, coronary heart disease, rheumatic heart disease, and other conditions.

Some of the significant lifestyle factors which lead to cardiovascular disease and difficulties are the use of tobacco, unhealthy diet, and physical inactivity increases the risk of heart attacks and strokes.Whereas the other risk factors for cardiovascular diseases are diabetes, high blood pressure, increased level of cholesterol levels.

CVDs are one of the major leading causes of death that affect more people as compared to any other disease across the globe.According to the World Health Organization, cardiovascular diseases are the number one cause of death across the world.

According to the WHO data published in 2017, states that, in 2016, approximately 17.9 million people died from CVDs, which was 31.0% of all the global deaths. Among these, about 85% death estimated due to stroke and heart attack that are mainly caused due to fatty deposits that block the blood vessels that prevent blood from flowing to the brain or heart. Also, strokes are caused due to bleeding from a blood vessel in the brain or from blood clots. Heart attacks and strokes are caused due to increased consumption of tobacco use, unhealthy diet and obesity, physical inactivity and rising alcohol consumption, hypertension, and diabetes.
As per the data estimated by the European Cardiovascular Disease Statistics 2017, cardiovascular disease (CVD) causes 3.9 million deaths and more than 1.8 million deaths in Europe every year. The CVD accounts for 45.0% of all deaths in Europe and 37.0% of all deaths in the EU. CVD is the primary reason for the death of men and women in all countries. Furthermore, as per the American Heart Association (AHA) 2019 statistics, 121.5 million adults in the U.S. which are around half of the US adult population, suffer from cardiovascular disease.
In 2018, the diagnostics segment accounted for the largest market share in the Europe immunohistochemistry market by the application.The advancements in immunohistochemistry have extended the use of technology to diagnose various type of chronic diseases.

The molecular diagnostics appplications have enabled to the treated patient as per their genetic make-up also the diagnosis through immunohistochemistry has increased the use in the precision medicine. Also, the cost-effective nature of the immunochemistry is driving significant growth across the region.
In 2018, the antibodies held the largest market share of the immunochemistry market, by product.This segment is also expected to dominate the market in 2027.

Moreover, the reagent segment is anticipated to register the highest CAGR in the market during the forecast period, since they form an essential component of any reaction and can be chosen as per the result to be obtained.
In 2018, the hospital & diagnostic laboratories segment held the most significant market share of the immunochemistry market, by the end-user.This segment is also expected to dominate the market in 2027.

Also, the segment is expected to grow at the fastest rate during the coming years owing to the rise in the prevalence of infectious diseases, cancer, and autoimmune disorders.
Some of the major primary and secondary sources for immunochemistry included in the report are, Federation of AIDS Organisations (AFAO), Agência Nacional de Vigilância Sanitária (ANVISA), HIV and AIDS organization (AVERT), Centers for Disease Control and Prevention (CDC), Centers for Diabetes and Endocrinology (CDE), Council of Scientific and Industrial Research (CSIR) and others.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off

($3000)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.

ref:plp2020

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on